Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK discusses action after confirmation new COVID strain spreads more quickly

Sat, 19th Dec 2020 13:12

* UK says new COVID strain spreads more quickly

* Govt to consider urgent action to curb rise in cases

* Urgent work to see if new strain affects mortality rate
(Recasts with chief medical officer)

By Michael Holden

LONDON, Dec 19 (Reuters) - British Prime Minister Boris
Johnson was discussing with his senior ministers on Saturday
what urgent action to take after it was confirmed that a new
strain of the COVID-19 virus could spread more quickly and lead
to a surge in cases.

England's Chief Medical Officer Chris Whitty said that while
there was no current evidence the variant of the novel
coronavirus caused a higher mortality rate or impacted vaccines,
urgent work was underway to confirm this.

"We have alerted the World Health Organisation and are
continuing to analyse the available data to improve our
understanding," Whitty said in a statement.

The government said on Monday that a rise in infections
across London and southeast England might be linked to a new,
more transmissible variant of the virus.

Johnson will hold a news conference with Whitty and the
government's chief scientific adviser at about 1600 GMT amid
suggestions that he will announce new urgent measures to try to
address the rise in cases caused by the variant COVID strain.

Britain reported 28,507 new COVID-19 cases on Friday and 489
deaths, with the reproduction "R" number estimated to be between
1.1 and 1.2, meaning the number of cases is rapidly increasing.

Johnson said on Friday he hoped England would not need to go
into a third lockdown after Christmas and has so far resisted
calls to change plans to ease restrictions for five days over
the festive period, allowing three separate households to meet
indoors.

Much of the country, including London, is currently in the
highest of a three-tier system of restrictions to curb the
spread. The Daily Telegraph newspaper said ministers could now
announce curbs on travel between southeast England, including
the capital, and the rest of the country.

"Failing to act decisively now, will mean further suffering.
We must keep asking ourselves 'are we doing enough, are we
acting quickly enough'," Jeremy Farrar, director of the Wellcome
Trust and a member of the government's Scientific Advisory Group
for Emergencies (SAGE), said on Twitter.

The opposition Labour Party said the tiered system had
failed to curb the virus's spread.

"It has been apparent for some days that the virus is again
out of control in parts of the country," said Jonathan Ashworth,
Labour's health spokesman.
(Additional reporting by Elizabeth Piper;
Editing by Ros Russell, William Maclean, Catherine Evans)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.